LINC00346

ncRNA information

ncRNA name

LINC00346

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-342-5p

Cancer information

Cancer name

Nasopharyngeal Carcinoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p

Tissue resource

nasopharyngeal carcinoma specimens and adjacent specimens

nasopharyngeal carcinoma cell lines SUNE1

nasopharyngeal carcinoma cell lines CNE2

nasopharyngeal carcinoma cell lines HNE1

nasopharyngeal carcinoma cell lines C666

immortalized nasopharyngeal epithelial cell lines NP69

Experiment

None


Institute

First Affiliated Hospital of Zhengzhou University

American Type Culture Collection

Country

China

United States

Continent

Asia

North Amercian